Clinical trial

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

NCT05273827

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-03-22

PhaseN/A

Study timeline

Study start (actual)2022-03-22Date precision: day

Registry last updated2024-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Immunotherapyunresolved

Analgesiaunresolved

NSCLCunresolved

Deliriumunresolved

Interventions

neoadjuvant immunotherapyDRUG

Neoadjuvant chemotherapyDRUG

Sponsors & collaborators

Tianjin Medical University Cancer Institute and Hospitallead sponsor

Tianjin Medical University General Hospitalcollaborator

Tianjin Chest Hospitalcollaborator

Mapped research locations

TianjinChina2 TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05273827 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.